In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci:: first results from Turkey

被引:4
作者
Arslan, H [1 ]
Azap, ÖK [1 ]
Ergin, F [1 ]
Karaman, SÖ [1 ]
Oruç, E [1 ]
机构
[1] Baskent Univ, Fac Med, Dept Clin Microbiol & Infect Dis, TR-06490 Ankara, Turkey
关键词
D O I
10.1016/j.ijantimicag.2004.03.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:642 / 643
页数:2
相关论文
共 10 条
[1]  
[Anonymous], [No title captured]
[2]   In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers [J].
Barry, AL ;
Fuchs, PC ;
Brown, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1919-1922
[3]   Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001 [J].
Critchley, IA ;
Draghi, DC ;
Sahm, DF ;
Thornsberry, C ;
Jones, ME ;
Karlowsky, JA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :639-649
[4]   Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media [J].
Fuchs, PC ;
Barry, AL ;
Brown, SD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (04) :557-561
[5]  
JONES RN, 1987, ANTIMICROB AGENTS CH, V45, P1919
[6]   The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates [J].
King, A ;
Phillips, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (02) :219-223
[7]   In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens [J].
Petersen, PJ ;
Bradford, PA ;
Weiss, WJ ;
Murphy, TM ;
Sum, PE ;
Projan, SJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2595-2601
[8]   The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species [J].
Richter, SS ;
Kealey, DE ;
Murray, CT ;
Heilmann, KP ;
Coffman, SL ;
Doern, GV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :123-127
[9]   Development of daptomycin for Gram-positive infections [J].
Tally, FP ;
DeBruin, MF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :523-526
[10]  
TONGCHAUN L, 2001, 39 M INF DIS SOC AM